Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glibenclamide for Severe Traumatic Brain Injury
NCT05148403Phase 2Unknown
- Sponsor
- Beijing Tiantan Hospital
- Start
- Oct 2021
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of glibenclamide in traumatic brain injury (TBI), sponsored by Beijing Tiantan Hospital. Status: unknown.
02
Drugs
glibenclamide
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT05148403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05148403.